In vivo tracking of neural progenitor cell migration to glioblastomas.

The ability to noninvasively track the migration, engraftment, and proliferation of neural progenitor cells (NPCs) has significant clinical and research implications. The purpose of our study was to explore the macroscopic migratory capabilities of NPCs toward brain tumors after implantation into nude mice. We stably transfected C17.2 NPCs with the firefly luciferase gene (F-luc) and implanted cells into (1) the contralateral brain parenchyma (2 x 10(6) cells), (2) the ventricles (2 x 10(6) cells), (3) the vasculature (1 x 10(5) cells), or (4) the intraperitoneal cavity (5 x 10(6) cells) of mice bearing intracranial gliomas (Gli36). Using serial bioluminescence imaging, migration of parenchymally injected cells was observed across the corpus callosum, first detected at 1 week, with maximal density at the tumor site 2-3 weeks after implantation. Similar patterns were also observed with intraventricular injections; however, tumors were populated earlier, presumably because of the shorter distance to travel. Intravenous injections resulted in more modest tumoral NPC populations, whereas virtually no cells could be identified in tumors after intraperitoneal injection. These results confirm the migratory capability of NPCs over considerable distances and their preferential accumulation in brain tumors on CNS rather than peripheral injection.

[1]  E. Snyder,et al.  Neural Stem Cells as Engraftable Packaging Lines Can Mediate Gene Delivery to Microglia: Evidence from Studying Retroviral env-Related Neurodegeneration , 1999, Journal of Virology.

[2]  Ralph Weissleder,et al.  Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.

[3]  X. Breakefield,et al.  Gene Therapy for Brain Tumors , 1995, Brain pathology.

[4]  Melitta Schachner,et al.  Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons , 2002, Nature Biotechnology.

[5]  J. D. Macklis,et al.  Multipotent neural precursors can differentiate toward replacement of neurons undergoing targeted apoptotic degeneration in adult mouse neocortex. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[6]  H. Land,et al.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. , 1990, Nucleic acids research.

[7]  C. Cepko,et al.  Multipotent neural cell lines can engraft and participate in development of mouse cerebellum , 1992, Cell.

[8]  P. Black,et al.  Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[9]  C. Cepko,et al.  Establishment and characterization of multipotent neural cell lines using retrovirus vector-mediated oncogene transfer. , 1990, Journal of neurobiology.

[10]  R. Blasberg,et al.  Imaging the expression of transfected genes in vivo. , 1995, Cancer research.

[11]  M. Apuzzo,et al.  Cellular and Molecular Neurosurgery: Pathways from Concept to Reality-Part I: Target Disorders and Concept Approaches to Gene Therapy of the Central Nervous System. , 1997, Neurosurgery.

[12]  R. Weissleder,et al.  Selective uptake of viral and monocrystalline particles delivered intra-arterially to experimental brain neoplasms. , 1995, Human gene therapy.

[13]  Jeff W M Bulte,et al.  In Vivo Magnetic Resonance Tracking of Magnetically Labeled Cells after Transplantation , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[14]  K. Hahm,et al.  Over-expression of ERT(ESX/ESE-1/ELF3), an ets-related transcription factor, induces endogenous TGF-β type II receptor expression and restores the TGF-β signaling pathway in Hs578t human breast cancer cells , 2000, Oncogene.

[15]  Simon R. Cherry,et al.  In vivo imaging of neuronal activation and plasticity in the rat brain by high resolution positron emission tomography (microPET) , 2000, Nature Biotechnology.

[16]  R. Raghupathi,et al.  Transplanted Neural Stem Cells Survive, Differentiate, and Improve Neurological Motor Function after Experimental Traumatic Brain Injury , 2002, Neurosurgery.

[17]  K. Black,et al.  Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. , 2002, Cancer research.

[18]  A. Álvarez-Buylla,et al.  Stem cells in the developing and adult nervous system. , 1998, Journal of neurobiology.

[19]  X. Breakefield,et al.  Prodrug activation enzymes in cancer gene therapy , 2000, The journal of gene medicine.

[20]  A. Jacobs,et al.  Green fluorescent protein as a reporter for retrovirus and helper virus‐free HSV‐1 amplicon vector‐mediated gene transfer into neural cells in culture and in vivo , 1997, Neuroreport.

[21]  A. Jacobs,et al.  Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  E. Galun,et al.  Imaging transgene expression in live animals. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[23]  E. Snyder,et al.  Neural progenitor cell engraftment corrects lysosomal storage throughout the MRS VII mouse brain , 1995, Nature.